[EN] JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF [FR] DÉRIVÉS DE QUINAZOLINE MODULANT LES JAK KINASES ET LEURS PROCÉDÉS D'UTILISATION
JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND THEIR USE IN METHODS
申请人:Ambit Biosciences Corporation
公开号:EP2401267B1
公开(公告)日:2014-01-15
JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF
申请人:Ambit Biosciences Corporation
公开号:EP2401267A1
公开(公告)日:2012-01-04
[EN] JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF<br/>[FR] DÉRIVÉS DE QUINAZOLINE MODULANT LES JAK KINASES ET LEURS PROCÉDÉS D'UTILISATION
申请人:AMBIT BIOSCIENCES CORP
公开号:WO2010099379A8
公开(公告)日:2010-11-25
ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF
申请人:Armstrong Robert C.
公开号:US20120053176A1
公开(公告)日:2012-03-01
Provided herein is a method of preventing, treating, or ameliorating one or more symptoms of an adenosine A
3
-mediated condition, disorder, or disease, with a compound of Formula I. Also provided herein is a method of preventing, treating, or ameliorating one or more symptoms of glaucoma or ocular hypertension. Further provided herein is a method of modulating the activity of an adenosine A
3
receptor.